Josep M. Aran
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis.
Journal: American journal of physiology. Cell physiology
Published: November 25, 2025
TNFRSF1B Signaling Blockade Protects Airway Epithelial Cells from Oxidative Stress.
Journal: Antioxidants (Basel, Switzerland)
Published: January 19, 2024
C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients.
Journal: Pharmacological research
Published: June 02, 2023
The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity.
Journal: Frontiers in immunology
Published: February 25, 2022
Genome-Wide RNAi Screening Identifies Novel Pathways/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity.
Journal: Antioxidants (Basel, Switzerland)
Published: November 08, 2021
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
Journal: International journal of molecular sciences
Published: September 21, 2021
Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.
Journal: International journal of molecular sciences
Published: November 20, 2020
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis.
Journal: Molecular therapy. Nucleic acids
Published: October 14, 2020
In vivo CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney Immunostaining.
Journal: Bio-protocol
Published: September 30, 2020
Reactive Oxygen Species: Drivers of Physiological and Pathological Processes.
Journal: Journal of inflammation research
Published: August 28, 2020
Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis.
Journal: Kidney international
Published: December 21, 2018
Exploring the Immunomodulatory Moonlighting Activities of Acute Phase Proteins for Tolerogenic Dendritic Cell Generation.
Journal: Frontiers in immunology
Published: December 20, 2017
Last Updated: 09/26/2026